Huo H - Search Results

1

Discovery of ANO1 Inhibitors based on Machine learning and molecule docking simulation approaches.

Zhong J, Xuan W, Lu S, Cui S, Zhou Y, Tang M, Qu X, Lu W, Huo H, Zhang C, Zhang N, Niu B. Zhong J, et al. Among authors: huo h. Eur J Pharm Sci. 2023 May 1;184:106408. doi: 10.1016/j.ejps.2023.106408. Epub 2023 Feb 24. Eur J Pharm Sci. 2023. PMID: 36842513 Free article.

2

Study of drug-drug combinations based on molecular descriptors and physicochemical properties.

Niu B, Xing Z, Zhao M, Huo H, Huang G, Chen F, Su Q, Lu Y, Wang M, Yang J, Chen L, Tang L, Zheng L. Niu B, et al. Among authors: huo h. Comb Chem High Throughput Screen. 2016;19(2):153-60. doi: 10.2174/1386207319666151110122931. Comb Chem High Throughput Screen. 2016. PMID: 26552439

3

Identifying Cancer Targets Based on Machine Learning Methods via Chou's 5-steps Rule and General Pseudo Components.

Liang R, Xie J, Zhang C, Zhang M, Huang H, Huo H, Cao X, Niu B. Liang R, et al. Among authors: huo h. Curr Top Med Chem. 2019;19(25):2301-2317. doi: 10.2174/1568026619666191016155543. Curr Top Med Chem. 2019. PMID: 31622219 Review.

4

Telmisartan relieves liver fibrosis and portal hypertension by improving vascular remodeling and sinusoidal dysfunction.

Zheng L, Zhao Z, Lin J, Li H, Wu G, Qi X, Lou X, Bao Y, Huo H, Luo M. Zheng L, et al. Among authors: huo h. Eur J Pharmacol. 2022 Jan 15;915:174713. doi: 10.1016/j.ejphar.2021.174713. Epub 2021 Dec 21. Eur J Pharmacol. 2022. PMID: 34942161

5

Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.

Fan Q, Wu G, Chen M, Luo G, Wu Z, Huo H, Li H, Zheng L, Luo M. Fan Q, et al. Among authors: huo h. Eur J Pharmacol. 2024 Feb 5;964:176278. doi: 10.1016/j.ejphar.2023.176278. Epub 2023 Dec 27. Eur J Pharmacol. 2024. PMID: 38158116

6

Imperatorin attenuates CCl₄-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways.

Zhao Z, Fan Q, Zhang C, Zheng L, Lin J, Chen M, Wu G, Li H, Huo H, Zhao Q, Luo M. Zhao Z, et al. Among authors: huo h. Eur J Pharmacol. 2024 Oct 5;980:176833. doi: 10.1016/j.ejphar.2024.176833. Epub 2024 Jul 31. Eur J Pharmacol. 2024. PMID: 39089464

7

Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection.

Zhang C, Lin J, Ni X, Li H, Zheng L, Zhao Z, Qi X, Huo H, Lou X, Fan Q, Luo M. Zhang C, et al. Among authors: huo h. Front Oncol. 2021 Sep 28;11:731989. doi: 10.3389/fonc.2021.731989. eCollection 2021. Front Oncol. 2021. PMID: 34650917 Free PMC article.

8

Salivary biomarkers-assisted ultrasound-based differentiation of malignant and benign thyroid nodules.

Zhao Z, Ren T, Zhao Y, Xu W, Xie R, Lin J, Li H, Zheng L, Zhang C, Huo H, Luo M, Fei J, Gu J. Zhao Z, et al. Among authors: huo h. Gland Surg. 2022 Jan;11(1):196-206. doi: 10.21037/gs-21-864. Gland Surg. 2022. PMID: 35242681 Free PMC article.

9

AMP-activated protein kinase (AMPK)/Ulk1-dependent autophagic pathway contributes to C6 ceramide-induced cytotoxic effects in cultured colorectal cancer HT-29 cells.

Huo HZ, Wang B, Qin J, Guo SY, Liu WY, Gu Y. Huo HZ, et al. Mol Cell Biochem. 2013 Jun;378(1-2):171-81. doi: 10.1007/s11010-013-1608-8. Epub 2013 Mar 19. Mol Cell Biochem. 2013. PMID: 23508272

10

Reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis.

Wu J, Tian B, Yang J, Huo H, Song Z, Yu J, Gu Y. Wu J, et al. Among authors: huo h. Transl Cancer Res. 2020 Feb;9(2):774-785. doi: 10.21037/tcr.2019.12.12. Transl Cancer Res. 2020. PMID: 35117423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

950 results

Search Page

Filters